In a procedural outcome that underscores the critical importance of compliance with service of process requirements, the U.S. District Court for the Northern District of Texas dismissed patent infringement case No. 3:23-cv-01744 — Omnitek Partners, LLC v. Huawei Technologies, Co., Ltd. — without prejudice on April 3, 2024. The case, which centered on U.S. Patent No. 7,272,293 and accused Huawei’s wearable technology products of infringement, never reached the merits stage. Instead, it collapsed on a fundamental procedural requirement: proper service of summons and complaint.

For patent attorneys, IP professionals, and R&D leaders operating in the competitive wearable technology space, this case delivers a timely reminder that even well-founded patent infringement claims can be derailed by procedural missteps. The dismissal, while without prejudice — meaning Omnitek retains the right to refile — consumed 243 days and produced no substantive adjudication on the patent’s validity or Huawei’s alleged infringement of its smartwatch and fitness band product lines.

Case Overview

The Parties

The Patent at Issue

The asserted patent, U.S. Patent No. 7,272,293 (Application No. 10/639,001), covers technology relevant to wearable device functionality. The patent’s claims, as implicated by the products accused, appear directed toward signal processing or data management features embedded in consumer wearables — a technology area experiencing intense patent assertion activity globally.

The Accused Products

Omnitek accused two product lines of infringing the ‘293 patent:

• • Huawei Band and Fit products — fitness tracking wearables
• • Huawei GT and Ultimate Watches — premium smartwatch lines

These products represent significant revenue segments in Huawei’s consumer division, making the infringement allegations commercially meaningful, though the case never progressed to damages quantification.

Legal Representation

Omnitek was represented by The Mort Law Firm PLLC, with attorneys Raymond W. Mort III, Anthony Wenn, and William Cory Spence on record. No defense counsel appeared for Huawei Technologies or Huawei Device USA, Inc. — a notable absence consistent with the service of process failure that ultimately resolved the case.

Litigation Timeline & Procedural History

Omnitek filed its complaint in the Northern District of Texas on August 4, 2023 — a venue historically favored by patent plaintiffs for its docket efficiency and experienced IP judiciary. The case was assigned to Chief Judge Jane J. Boyle, a seasoned federal jurist in the Northern District.

After filing its First Amended Complaint, Omnitek failed to complete service of process on either Huawei defendant within the timeframe prescribed by Federal Rule of Civil Procedure 4(m). The court intervened, issuing an order requiring Omnitek to either complete service or show written cause for the failure by March 29, 2024. The court explicitly warned that noncompliance would result in dismissal without further notice.

Omnitek did neither. The case was dismissed on April 3, 2024 — 243 days after filing — without any substantive ruling on infringement or validity.

The Verdict & Legal Analysis

Outcome

The Northern District of Texas dismissed Case No. 3:23-cv-01744 without prejudice under Federal Rule of Civil Procedure 4(m). No damages were awarded. No injunctive relief was considered. No claim construction occurred. The dismissal was purely procedural.

A without prejudice dismissal preserves Omnitek’s right to refile — provided applicable statutes of limitations have not expired and service can be properly effectuated in a subsequent action.

Verdict Cause Analysis

The dismissal was triggered exclusively by failure to serve process — not by any finding on patent validity, claim scope, or infringement. Under FRCP 4(m), a plaintiff must serve defendants within 90 days of filing the complaint. Failure to comply authorizes the court to dismiss the action or order service within a specified time.

Chief Judge Boyle’s order gave Omnitek an explicit cure period with a hard deadline and unambiguous warning language. When Omnitek failed to act, dismissal was mandatory under the court’s prior order and Rule 4(m).

The absence of any defense counsel of record for Huawei is particularly notable. Serving a foreign defendant — Huawei Technologies, Co., Ltd. is a Chinese multinational — frequently triggers complications under the Hague Convention on Service Abroad, which governs service in civil and commercial matters between signatory nations. China, while a signatory, imposes procedural requirements that can significantly delay service, including translation requirements and routing through Chinese central authorities. This structural challenge may explain — though not legally excuse — Omnitek’s service failure.

Legal Significance

While procedurally unremarkable, this case carries instructive weight:

1. Foreign defendant service complexity is a recurring obstacle in U.S. patent litigation against Chinese technology companies. Courts have limited tolerance for delays absent demonstrated diligence.
2. The Northern District of Texas enforces compliance orders strictly. Plaintiff counsel must anticipate service complications when asserting patents against foreign defendants and build remediation time into litigation planning.
3. Without prejudice dismissal preserves optionality for Omnitek but introduces delay, additional cost, and potential estoppel risks in any refiled action.

Strategic Takeaways

For Patent Holders & Plaintiff Counsel:

• When asserting patents against foreign defendants, consult international service specialists before filing, not after service failures arise.
• Consider Hague Convention timelines when selecting filing dates and negotiate extended service deadlines with the court proactively under FRCP 4(m).
• Document all service attempts meticulously to support any “show cause” response.

For Accused Infringers:

• Non-appearance does not guarantee dismissal; it creates risk. Huawei’s absence here resulted in dismissal, but in other procedural postures, default judgment exposure is real.
• Monitor dockets for patent assertion entity (PAE) filings targeting your product lines, even where service has not been completed.

For R&D & In-House IP Teams:

• Patent No. 7,272,293 remains a live assertion risk for wearable technology developers. The dismissal was procedural — not a ruling that Huawei’s products do not infringe.
• Companies in the wearable technology space should include the ‘293 patent in freedom-to-operate (FTO) analysis for fitness trackers and smartwatch product lines.

Industry & Competitive Implications

The wearable technology patent landscape is intensely contested. Smartwatches and fitness trackers sit at the intersection of biometric sensing, wireless communication, and consumer electronics — all areas of dense patent activity. Patent assertion entities have increasingly targeted this segment, particularly against non-U.S. manufacturers with large U.S. sales volumes.

Huawei’s GT, Ultimate Watch, and Band/Fit product lines compete in a global market valued in the tens of billions annually. Patent infringement findings — had this case proceeded — could have resulted in injunctive relief affecting U.S. product importation, particularly significant given Huawei’s existing regulatory constraints in the American market.

For other wearable technology companies — including Fitbit (Google), Samsung, Garmin, and emerging Chinese competitors — this case signals continued PAE attention to the wearable segment. The ‘293 patent may resurface in a refiled action or in assertions against other defendants.

The case also reflects a broader litigation trend: PAEs increasingly file against foreign technology giants in U.S. courts, leveraging the commercial significance of the U.S. market as settlement leverage. Service complications with Chinese defendants are a known friction point that sophisticated plaintiff firms must navigate more effectively.